Untreated thyroid problems during pregnancy might be doing more than just making moms feel tired and unwell — they could be quietly shaping a child’s brain and future behavior in ways that many families never see coming. And this is the part most people miss: it’s not simply “having” a thyroid condition that seems to matter most, but whether the thyroid hormones actually stay out of balance during pregnancy.
Researchers looking at births in Israel found that when mothers had chronic hypothyroidism (a long-term underactive thyroid) but were adequately treated and kept in a healthy hormone range, their children did not show an increased risk of autism spectrum disorder (ASD). In statistical terms, chronic hypothyroidism on its own was not significantly linked with ASD in offspring (adjusted hazard ratio 0.47, 95% confidence interval 0.15-1.48), which suggests that well-managed thyroid disease may not raise autism risk in a meaningful way. However, the story changed when chronic hypothyroidism was combined with hypothyroidism that actually appeared during pregnancy.
When mothers had both long-standing hypothyroidism and gestational hypothyroidism (thyroid hormone imbalance specifically during pregnancy), their children faced more than twice the risk of ASD compared with children of mothers who had normal thyroid function. The adjusted hazard ratio in this group was 2.61 (95% CI 1.44-4.74), indicating a substantial increase in risk, not just a small statistical fluctuation. But here’s where it gets controversial: the level of risk seemed to climb the longer the pregnancy was exposed to thyroid hormone imbalance, suggesting a dose-response pattern rather than an all-or-nothing effect.
The study showed that exposure to combined chronic and gestational hypothyroidism in just one trimester was associated with a higher ASD risk (adjusted HR 1.35, 95% CI 1.02-2.44). If two trimesters were affected, the risk rose further (adjusted HR 2.04, 95% CI 1.20-6.19), and when all three trimesters were involved, the risk climbed again (adjusted HR 2.87, 95% CI 1.10-9.94). For parents and clinicians, this suggests that longer periods of low or imbalanced thyroid hormone levels during pregnancy may be more harmful to fetal brain development than shorter, well-corrected episodes. At the same time, the researchers cautioned that these patterns cannot yet prove that thyroid imbalance directly causes ASD; other factors may still be playing a role.
Because of this, the authors emphasized that it appears to be the actual hormone imbalance during pregnancy — not simply carrying the label of a chronic thyroid condition — that is tied to ASD risk in children. In other words, a woman may have chronic hypothyroidism, but if her thyroid hormone levels are monitored and properly adjusted with medication, the risk to her child may not be elevated. This finding supports existing recommendations that pregnant women, and especially those with known thyroid issues, should have their thyroid hormone levels routinely checked and treated as needed to maintain euthyroidism (a normal thyroid state) throughout pregnancy.
These results build on a growing body of evidence that maternal thyroid function during pregnancy can influence how a baby’s brain develops. Earlier research had already suggested that thyroid problems in pregnancy might be linked with fetal neurodevelopmental issues, but many of those studies focused on screening and diagnosis, not on how well the thyroid problem was actually treated. This newer work brought maternal medication use and control of hormone levels into the spotlight, highlighting that simple diagnosis is not enough — what truly matters may be whether hormone levels are kept within a healthy range.
Thyroid hormones play an essential role in fetal neurogenesis and brain maturation, especially in early pregnancy. During the first trimester, the fetus mostly depends on the mother’s thyroid hormones, which cross the placenta and help guide critical steps in brain development. When those hormone levels are too low or unstable, previous studies have linked this to various developmental challenges in children, such as lower IQ scores and delays in expressive language skills and nonverbal cognitive abilities. This makes it easier to understand why prolonged hormone imbalance in the mother could potentially influence the long-term neurological outcomes of the child.
The authors noted that their findings open up new lines of research into the biological mechanisms connecting abnormal thyroid hormone levels in the mother with changes in fetal brain development. Future studies may look more closely at how specific thyroid-related pathways influence neural growth, synapse formation, and brain connectivity in the developing fetus. Since thyroid dysfunction is relatively common in women of reproductive age, and since effective, accessible treatments like levothyroxine exist, understanding this relationship more clearly has important real-world implications for prenatal care and child health.
The study itself was a retrospective cohort analysis of live singleton births at Soroka University Medical Center in Israel between January 2011 and December 2017. Researchers linked mothers’ identification numbers across three medical databases that tracked chronic maternal diagnoses, prenatal and perinatal information, and later ASD diagnoses in their children. The median age at ASD diagnosis was 4.6 years, meaning many children were followed long enough for autism to be recognized and documented in clinical records.
Out of 51,296 women in the study, 4,409 (8.6%) were found to have abnormal thyroid function. These women had at least one thyroid function test performed in each trimester, reflecting closer monitoring than in those with normal thyroid function. Among the women with abnormal thyroid results, 1,161 had chronic hypothyroidism, 1,600 had gestational hypothyroidism, and 1,054 had both chronic and gestational hypothyroidism, representing a sizable group with overlapping long-term and pregnancy-specific thyroid issues.
A smaller number of women had hyperthyroidism (an overactive thyroid). One hundred women had chronic hyperthyroidism, 376 had gestational hyperthyroidism, and 15 had both chronic and gestational hyperthyroidism. While these groups were included and described, the central findings about ASD risk were most striking in the context of hypothyroidism, especially when chronic disease and gestational imbalance occurred together. Interestingly, when thyroid dysfunction was limited to gestational thyroid problems alone, ASD risk in the children did not differ from that in the group of women with normal thyroid function.
Women with abnormal thyroid function differed in several ways from those with normal thyroid function, which might also influence pregnancy and child outcomes. They tended to be older and were more likely to have used assisted reproductive technologies such as in vitro fertilization. They also had higher rates of pregnancy and birth-related complications, including gestational diabetes, hypertension, cesarean sections, and assisted deliveries. The researchers used statistical adjustments to account for these differences, but they acknowledged that some underlying reproductive risk factors could still confound the observed relationship between thyroid dysfunction and ASD.
The study also had important limitations that the authors openly discussed. They lacked detailed information on levothyroxine treatment, such as exact doses, adherence patterns, or how well treatment controlled hormone levels throughout pregnancy. They also did not have data on maternal iodine status, which can influence thyroid function, or on maternal thyroid antibodies, which might signal autoimmune thyroid disease and add another layer of risk. These gaps mean that some key influences on thyroid health and fetal development were not directly measured.
Here’s where a subtle controversy comes in: some might interpret these findings as evidence that better thyroid screening and more aggressive treatment during pregnancy could help prevent some cases of ASD. Others will point out that autism is complex and influenced by many genetic and environmental factors, so focusing too heavily on one modifiable factor could oversimplify the issue. Is it fair to suggest that tighter thyroid control during pregnancy might reduce autism risk, or does that risk overselling what current evidence can truly support?
That tension makes this study both hopeful and provocative. On one hand, it suggests a potentially actionable pathway: regularly monitor maternal thyroid function before and during pregnancy, treat hypothyroidism effectively, and limit the duration of hormone imbalance as much as possible. On the other hand, it raises difficult questions about how much responsibility should be placed on mothers and clinicians when so many aspects of neurodevelopment remain beyond anyone’s control. What do you think: should findings like these change how aggressively we screen and treat thyroid problems in pregnancy, or is it too soon to draw such strong conclusions? And do you see this as empowering information for parents-to-be, or as a source of added pressure and worry? Share where you stand — do you strongly agree, strongly disagree, or fall somewhere in the middle on how much weight this kind of study should carry in shaping pregnancy care and autism discussions?
